Although a number of pharmacological approaches have been investigated in recent years, few therapeutically effective and safe products have been developed (3)
"If India is starting to manufacture GLP-1s at a large scale, that will not all stay in India, whatever companies try, countries try to prevent it from coming in," Ben van der Schaaf, Partner at Arthur D
It should be solved by means of a radical restructuring of society
Jiang W, Wang Q, Zhang X, Yang H, Yang X
Unlike some medications that require careful tapering, GLP-1 drugs such as semaglutide, dulaglutide, and liraglutide do not typically cause physical dependence or withdrawal symptoms
Phase 2 results have been published in obesity (Jastreboff and colleagues, N Engl J Med, 2023) and in type 2 diabetes (Rosenstock and colleagues, Lancet, 2023), and the compound has since progressed into the phase 3 TRIUMPH programme